Lv1
50 积分 2023-03-13 加入
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
1天前
待确认
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
1天前
已完结
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
1个月前
已完结
Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer
2个月前
已完结
Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results
3个月前
已完结
As-Needed Blood Pressure Medication and Adverse Outcomes in VA Hospitals
3个月前
已完结
Psoriasis Risk With Immune Checkpoint Inhibitors
3个月前
已完结
What Is the Optimal Locoregional Approach for Recurrent Hepatocellular Carcinoma?
3个月前
已关闭
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial
3个月前
已完结
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
8个月前
已完结
皖公网安备34019202002308
